Insider Stock Trading History of Scopa James Paul


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Scopa James Paul since year 2005. The trader's CIK number is 1356950. At the time of this reporting, Scopa James Paul is the Director of Conatus Pharmaceuticals Inc . (stock ticker symbol CNAT). See this page for all insider trading activities at Conatus Pharmaceuticals Inc .

Note that in the past Scopa James Paul also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Scopa James Paul since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-07-30 CNAT Conatus Pharmaceuticals Inc Buy 165,265 11.00 1,817,915
2009-02-11 PLI Peplin Inc Buy 999 8.00 7,992
2009-02-12 PLI Peplin Inc Buy 1,249 8.20 10,241
2009-02-09 PLI Peplin Inc Buy 999 8.00 7,992
2009-02-05 PLI Peplin Inc Buy 2,648 7.80 20,654
2009-01-23 PLI Peplin Inc Buy 6,029 8.00 48,232
2009-01-27 PLI Peplin Inc Buy 1,678 8.20 13,759
2009-01-21 PLI Peplin Inc Buy 932 8.00 7,456
2009-01-22 PLI Peplin Inc Buy 2,583 8.10 20,922
2009-01-15 PLI Peplin Inc Buy 1,598 7.80 12,464
2009-01-16 PLI Peplin Inc Buy 7,340 8.20 60,187
2009-01-19 PLI Peplin Inc Buy 899 8.20 7,371
2009-01-20 PLI Peplin Inc Buy 45 8.40 378
2009-01-13 PLI Peplin Inc Buy 6,911 7.03 48,584

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scopa James Paul (Director of Conatus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.